US HB679 | 2021-2022 | 117th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 7-4)
Status: Introduced on February 1 2021 - 25% progression, died in committee
Action: 2021-02-02 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend the Office of National Drug Control Policy Reauthorization Act of 1998 to direct the Office of National Drug Control Policy to publish a list of drug control grant programs, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Effective Drug Control Strategy Act of 2021

Sponsors


History

DateChamberAction
2021-02-02HouseReferred to the Subcommittee on Health.
2021-02-01HouseReferred to the Committee on Oversight and Reform, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2021-02-01HouseIntroduced in House

Same As/Similar To

HB6311 (Related) 2022-11-01 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
SB3418 (Related) 2021-12-16 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Subjects


US Congress State Sources


Bill Comments

feedback